Table 2 Differences in prevalence of putative drug resistant SNPs among P. vivax populations.
Genotype | Drug | Population 1 | Population 2 | Population 3 | p-value |
---|---|---|---|---|---|
Pvdhfr:58R | SP (n, %) | 2 (5.2%) | 40 (65.5%) | 21 (63.6%) | < 0.0001 |
Pvmdr1:976F | CQ (n, %) | 0 (0%) | 2 (3.2%) | 4 (11.4%) | 0.0501 |
Pvdhps:382A | SP (n, %) | 1 (2.5%) | 30 (49.2%) | 4 (11.4%) | < 0.0001 |
Pvdhps:383G | SP (n, %) | 38 (52%) | 31 (100%) | 31 (100%) | < 0.0001 |